Igor Suchkov

Dr. Igor Suchkov

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2020 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
RKRoman E. Kalinin
Roman E. Kalinin
ISIgor Suchkov
Igor Suchkov
ЕKЕmma A. Klimentova
Еmma A. Klimentova
AEAndrey A. Egorov
Andrey A. Egorov
VPVladislav O. Povarov
Vladislav O. Povarov
Apoptosis is recognized as a programmed cell death controlled by genetic mechanisms and required for normal existence of an organism. Its main task is elimination of defective or mutant cells. The particles of dead cells are engulfed by macrophages with no development of inflammatory reaction. Apoptosis actively participates in embryogenesis, cellular homeostasis, elimination of tumor cells, and may be divided to three phases: signal, effector, and degradation. Its main components are cytoplasmic proteases caspases. Caspases exist in the cytoplasm in inactive condition in the form pf procaspases. Being activated, they break down to subunits. Proteins of Bcl-2 family are active participants of the mitochondrial pathway of apoptosis. They influence permeability of the outer membrane of mitochondria. Disorders in the mechanisms of apoptosis underlie many diseases including ischemic lesions, autoimmune disorders, malignant neoplasms. The ability to influence survival or death of cell is known to possess enormous therapeutic potential. At present, active research is under way to study signal pathways that control cell cycle and apoptosis. The article discusses the mechanisms participating in death of vascular endothelium and smooth muscle cells, potential role of apoptosis in atherosclerosis is also described.

15 June 2015 in Novosti Khirurgii
Verified
Journal Article
Closed access
SPSBEE HPE "Ryazan State Medical University named after I.P. Pavlov"
SBEE HPE "Ryazan State Medical University named after I.P. Pavlov"
RKRoman E. Kalinin
Roman E. Kalinin
APA.S. Pshennikov
A.S. Pshennikov
ISIgor Suchkov
Igor Suchkov

12 November 2023 in Problems of Endocrinology
Verified
Journal Article
Open access
PDF file
ESE. V. Shlyakhto
E. V. Shlyakhto
GSGennady T. Sukhikh
Gennady T. Sukhikh
VSV. N. Serov
V. N. Serov
IDI. I. Dedov
I. I. Dedov
GAG. P. Arutyunov
G. P. Arutyunov
NTN. I. Tapilskaya
N. I. Tapilskaya
Menopausal symptoms can disrupt the life course of women at the peak of their career and family life. Currently, the most effective treatment for these manifestations is menopausal hormone therapy (MHT). The presence of cardiovascular and metabolic diseases in itself does not exclude the possibility of prescribing MHT to relieve menopausal symptoms and improve quality of life. However, often an obstacle to the use of this type of hormonal therapy is the fear of doctors who are afraid of doing more harm to patients than good. Caution is especially important when it comes to women with underlying health conditions. Moreover, it should be recognized that there is a lack of high-quality research regarding the safety of MHT for major chronic non-infectious diseases and common comorbid conditions. The presented consensus document analyzed all currently available data obtained from clinical trials of various designs and created a set of criteria for the acceptability of prescribing MHT to women with concomitant cardiovascular and metabolic diseases. Based on the presented document, doctors of various specialties who advise women in menopause will receive an accessible algorithm that will allow them to avoid potentially dangerous situations and reasonably prescribe MHT in real practice.

3 July 2020 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Open access
PDF file
RKRoman E. Kalinin
Roman E. Kalinin
ISIgor Suchkov
Igor Suchkov
NMNina Mzhavanadze
Nina Mzhavanadze
NKNatalya V. Korotkova
Natalya V. Korotkova
ANAleksandr A. Nikiforov
Aleksandr A. Nikiforov
ESEkaterina A. Strelnikova
Ekaterina A. Strelnikova
Aim. To study and compare cytotoxicity of the main types of synthetic prostheses used in arterial reconstructive surgery, including polytetrafluoroethylene (PTFE) and polyethylene-terephthalate (Dacron). Materials and Methods. On the culture of human umbilical vein endothelial cells (HUVEC) of the 3rd passage, MTS test was conducted that is used in laboratory examinations with attraction of cellular technologies to study cytotoxicity of medical drugs and medical products. The test implies use of MTS reagent that is 3-(4,5-dimethylthiazol-2-il)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium; additionally phenazine methosulfate (PMS) was used that plays the role of electron-binding reagent. In the experiment, cells were incubated with PTFE and Dacron within 24 hours at 37ᵒC with 5% CO2. For control, HUVEC cultured in the standard growth medium, were used. In the presence of PMS, MTS was reduced by mitochondrial dehydrogenases of endothelial cells to formazan staining blue. Supernatant of cell cultures was evaluated by photocolorimetric method on Stat Fax 3200 analyzer (microplate reader) of Awareness technology Inc. Palm City Fl. (USA). Results. The lowest mean values were noted in Dacron group 0.21 (0.20-0.22) optical density units, the highest values were noted in the control group 0.36 (0.35-0.38); parameters in PTFE group were 0.35 (0.33-0.36). In comparison of the groups statistically significant differences were found between the control group and Dacron group (р0.001), control and PTFE group (р=0.037), Dacron and PTFE (р0.001). Incubation with Dacron led to suppression of metabolic activity of cells by 41.7% as compared to the control group (р0.001). Metabolic activity of cells exposed to PTFE, approached that of the control group, that is, it corresponded to the optimal conditions of culturing of endothelial cells in vitro. Conclusion. In comparison with polyethylene-terephthalate (Dacron), polytetrafluoro-ethylene (PTFE) showed the least suppression of metabolic activity of endothelial cells in vitro.

29 June 2022 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
RKRoman E. Kalinin
Roman E. Kalinin
ISIgor Suchkov
Igor Suchkov
EКEmma A. Кlimentova
Emma A. Кlimentova
AEAndrey A. Egorov
Andrey A. Egorov
VKVyacheslav V. Karpov
Vyacheslav V. Karpov
INTRODUCTION: The development and progression of atherosclerosis in different vascular pools remain unclear. Many studies have considered apoptosis to play a key role in the development of atherosclerosis; apoptosis is a programmed cell death with characteristic morphological signs aimed at providing homeostasis in an organism in general and in the vascular wall in particular. However, all studies that have been devoted to markers of apoptosis were mostly experimental and were conducted on either animals or grown cultures of different cells. The study aimed to examine markers of apoptosis (р53, sFas, Вах, and Всl-2) and proliferation (platelet-derived growth factor [PDGF] BB) in the vessel wall in the area of an atherosclerotic lesion in a patient with multifocal atherosclerosis. The clinical case was of interest because it allowed the assessment of biomarkers in both the area of progression of atherosclerotic lesion on an operated limb and the carotid pool in the long-term postoperative period. CONCLUSIONS: This case demonstrated that a patient with obliterating atherosclerosis of the lower limb arteries had an elevated level of pro-apoptotic markers р53 and Вах and PDGF ВВ as a marker of cell proliferation and migration, against the background reduced level of anti-apoptotic markers Всl-2 and sFas in comparison with their values in the normal arterial wall. The progression of atherosclerotic lesion in two vascular pools was associated with a further increase in the values of proapoptotic markers (р53 and Вах) and decrease in the values of Всl-2 and sFas compared with the initial samples. With this, the values of PDGF ВВ marker remained elevated relative to the initial level.

5 August 2021 in Vascular Specialist International
Verified
Journal Article
Open access
PDF file
RKRoman E. Kalinin
Roman E. Kalinin
ISIgor Suchkov
Igor Suchkov
NMNina Mzhavanadze
Nina Mzhavanadze
OZOlga N. Zhurina
Olga N. Zhurina
EKEmma A. Klimentova
Emma A. Klimentova
VPVladislav O. Povarov
Vladislav O. Povarov
Roman E. Kalinin, Igor A. Suchkov, Nina D. Mzhavanadze, Olga N. Zhurina, Emma A. Klimentova, and Vladislav O. Povarov. Vasc Specialist Int 2021;37:. https://doi.org/10.5758/vsi.210010